June 14, 2016 – FDA strengthens kidney injury warning on canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).
2016 – FDA strengthens kidney injury warning
Announcement Date: June 24, 2016
June 14, 2016 – FDA strengthens kidney injury warning on canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR).